FDA Approves First Treatment for MAS in Still Disease ...Middle East

Medscape - News
FDA Approves First Treatment for MAS in Still Disease
Emapalumab is approved for both adults and pediatric (newborn and older) patients with MAS in Still disease with an inadequate response or intolerance to glucocorticoids, or with recurrent MAS. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves First Treatment for MAS in Still Disease )

Apple Storegoogle play

Also on site :